Published in Front Psychiatry on June 23, 2014
Perspectives on stress resilience and adolescent neurobehavioral function. Neurobiol Stress (2014) 0.78
S-Nitrosylation in neurogenesis and neuronal development. Biochim Biophys Acta (2014) 0.76
Activation of chronic toxoplasmosis by transportation stress in a mouse model. Oncotarget (2016) 0.75
Stress-Induced Reduction of Dorsal Striatal D2 Dopamine Receptors Prevents Retention of a Newly Acquired Adaptive Coping Strategy. Front Pharmacol (2017) 0.75
Epigenetic programming by maternal behavior. Nat Neurosci (2004) 20.92
Stress and the individual. Mechanisms leading to disease. Arch Intern Med (1993) 10.27
Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry (2008) 9.54
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry (2005) 9.23
Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci (1998) 9.14
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci (2008) 6.97
Adolescent brain development: a period of vulnerabilities and opportunities. Keynote address. Ann N Y Acad Sci (2004) 6.74
Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci (2009) 6.22
The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull (2009) 6.03
Structural and functional brain development and its relation to cognitive development. Biol Psychol (2000) 5.40
Hierarchical organization of human cortical networks in health and schizophrenia. J Neurosci (2008) 5.19
Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics (2008) 4.96
Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat Rev Neurosci (2001) 4.94
Gene-environment interplay and psychopathology: multiple varieties but real effects. J Child Psychol Psychiatry (2006) 4.92
Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2012) 4.71
Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci (2002) 4.36
The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 4.16
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry (2010) 3.88
Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res (2003) 3.86
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci (2007) 3.82
The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry (2005) 3.68
Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex (2000) 3.37
Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry (2001) 3.19
The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology (2009) 3.01
Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet (2011) 2.99
Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. J Neurosci (2004) 2.93
Reciprocal regulation of the neural and innate immune systems. Nat Rev Immunol (2011) 2.87
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry (2011) 2.37
Changes in cerebral functional organization during cognitive development. Curr Opin Neurobiol (2005) 2.32
Effects of adverse experiences for brain structure and function. Biol Psychiatry (2000) 2.21
Association between promoter methylation of serotonin transporter gene and depressive symptoms: a monozygotic twin study. Psychosom Med (2013) 2.19
Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc Natl Acad Sci U S A (2002) 2.10
A new perspective on anhedonia in schizophrenia. Am J Psychiatry (2012) 2.08
Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders. J Abnorm Psychol (1998) 2.07
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl) (2004) 2.06
Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr Bull (2003) 2.04
Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol (2008) 2.00
Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex. Brain Cogn (2007) 1.94
Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus (2001) 1.87
Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep (2010) 1.87
Functional but not structural subgenual prefrontal cortex abnormalities in melancholia. Mol Psychiatry (2004) 1.83
Pediatric stress: hormonal mediators and human development. Horm Res (2003) 1.79
Positive and negative symptoms in families with schizophrenia. Schizophr Res (1993) 1.74
Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biol Psychiatry (2002) 1.72
Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry (2004) 1.70
Stress and development: behavioral and biological consequences. Dev Psychopathol (2001) 1.69
Chronic corticosterone exposure increases expression and decreases deoxyribonucleic acid methylation of Fkbp5 in mice. Endocrinology (2010) 1.65
Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Cereb Cortex (2007) 1.62
Cognitive and behavioral precursors of schizophrenia. Dev Psychopathol (1999) 1.60
Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder. Transl Psychiatry (2014) 1.59
Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet (2013) 1.57
Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia. Int J Dev Neurosci (2011) 1.56
The stress cascade and schizophrenia: etiology and onset. Schizophr Bull (2003) 1.56
The application of nonlinear Dynamic Causal Modelling for fMRI in subjects at high genetic risk of schizophrenia. Neuroimage (2013) 1.52
Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study. Arch Gen Psychiatry (2010) 1.52
Dynamic Network Connectivity: A new form of neuroplasticity. Trends Cogn Sci (2010) 1.48
A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. PLoS One (2012) 1.45
Models of brain function in neuroimaging. Annu Rev Psychol (2005) 1.42
Stress-related methylation of the catechol-O-methyltransferase Val 158 allele predicts human prefrontal cognition and activity. J Neurosci (2011) 1.41
The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology (2012) 1.40
Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci (2009) 1.37
The Copenhagen High-Risk Project, 1962-86. Schizophr Bull (1987) 1.34
Psychopathology among offspring of parents with schizophrenia: relationship to premorbid impairments. Schizophr Res (2008) 1.32
Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis. Hum Brain Mapp (2009) 1.32
Emotion processing in persons at risk for schizophrenia. Schizophr Bull (2008) 1.31
Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. Br J Psychiatry Suppl (2007) 1.31
From epigenesis to epigenetics: the case of C. H. Waddington. Ann N Y Acad Sci (2002) 1.30
Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state. Brain (2009) 1.29
Brain neuroplasticity in healthy, hyperactive and psychotic children: insights from neuroimaging. Neuropsychopharmacology (2007) 1.28
Schizophrenia. Lancet (1999) 1.28
Cortical brain development in schizophrenia: insights from neuroimaging studies in childhood-onset schizophrenia. Schizophr Bull (2007) 1.27
Social functioning in young people at risk for schizophrenia. Psychiatry Res (2007) 1.23
Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients. Transl Psychiatry (2014) 1.22
The New York high risk project to the Hillside recognition and prevention (RAP) program. Am J Med Genet (2002) 1.21
Peripheral SLC6A4 DNA methylation is associated with in vivo measures of human brain serotonin synthesis and childhood physical aggression. PLoS One (2012) 1.20
Working memory capacity in schizophrenia: a parametric fMRI study. Schizophr Res (2004) 1.19
Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res (2000) 1.19
An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy. Neuropharmacology (2012) 1.19
SLC6A4 methylation modifies the effect of the number of traumatic events on risk for posttraumatic stress disorder. Depress Anxiety (2011) 1.18
Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress: importance for psychiatric diseases. Neurotox Res (2004) 1.17
The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia. Mol Psychiatry (2013) 1.16
A measure of glucocorticoid load provided by DNA methylation of Fkbp5 in mice. Psychopharmacology (Berl) (2011) 1.16
Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis. Psychol Med (2011) 1.16
Premorbid indicators and risk for schizophrenia: a selective review and update. Schizophr Res (2005) 1.14
Experience of trauma and conversion to psychosis in an ultra-high-risk (prodromal) group. Acta Psychiatr Scand (2010) 1.14
Gene × environment vulnerability factors for PTSD: the HPA-axis. Neuropharmacology (2011) 1.13
Glucocorticoid-induced loss of DNA methylation in non-neuronal cells and potential involvement of DNMT1 in epigenetic regulation of Fkbp5. Biochem Biophys Res Commun (2012) 1.12
Sex differences in the serotonergic influence on the hypothalamic-pituitary-adrenal stress axis. Endocrinology (2010) 1.12
Childhood-onset schizophrenia: insights from neuroimaging studies. J Am Acad Child Adolesc Psychiatry (2009) 1.10
Imaging attention networks. Neuroimage (2011) 1.10
A short history of causal modeling of fMRI data. Neuroimage (2012) 1.10
Prefrontal cognitive systems in schizophrenia: towards human genetic brain mechanisms. Cogn Neuropsychiatry (2009) 1.10
The heritability of hedonic capacity and perceived stress: a twin study evaluation of candidate depressive phenotypes. Psychol Med (2008) 1.08
Social anhedonia and schizotypy: the contribution of individual differences in affective traits, stress, and coping. Psychiatry Res (2006) 1.07
Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.06
Stress and neurodevelopmental processes in the emergence of psychosis. Neuroscience (2013) 1.05
Stress and HPA-axis functioning in young people at ultra high risk for psychosis. J Psychiatr Res (2006) 1.05
A prospective study of stress autonomy versus stress sensitization in adolescents at varied risk for depression. J Abnorm Psychol (2010) 1.04
Risk factors for schizophrenia--all roads lead to dopamine. Eur Neuropsychopharmacol (2007) 1.04